What is Ozempic face?

Ozempic face is a clinically recognised term for the facial lipoatrophy — hollowing of the cheeks, temples, and jawline — that follows rapid or significant weight loss, whether caused by semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), bariatric surgery, or dietary-driven weight reduction. The mechanism is loss of subcutaneous facial fat faster than the overlying skin can retract or the dermis can produce new collagen. The face takes on an aged, gaunt, or deflated appearance that is often inconsistent with the patient's overall health and age. It is not a side effect exclusive to GLP-1 drugs — the same process occurs with any rapid weight loss.

What is Mounjaro face (and Mounjaro body)?

Mounjaro face is the same facial lipoatrophy described as Ozempic face — hollowing of the cheeks, temples, and jawline — when the weight loss comes from tirzepatide (Mounjaro, Eli Lilly), a dual GIP and GLP-1 receptor agonist now more common than semaglutide (Ozempic, Wegovy) among patients who come for this assessment. Mounjaro body is the matching loss of skin firmness over the abdomen, inner arms, and inner thighs. In a 2025 head-to-head trial, tirzepatide produced greater average weight loss than semaglutide, so these changes can be more marked. Treatment follows the same assessment as any rapid weight loss: facial volume and collagen restoration with biostimulators, and body laxity treated with biostimulators and radiofrequency microneedling once weight is stable.

How to restore facial volume?

Facial volume restoration after significant weight loss requires rebuilding both the collagen scaffold and the structural volume that has been lost. Sculptra (poly-L-lactic acid, Galderma) is typically the first-line choice: it stimulates progressive collagen synthesis over 3-6 months and addresses the underlying structural deficit rather than simply filling space. For patients who need faster interim results, HarmonyCa (HA plus CaHA hybrid, Allergan) or Radiesse (calcium hydroxyapatite, Merz) provide immediate volumisation alongside biostimulatory effects. Most patients require 2-3 sessions of the primary biostimulator, spaced 4-8 weeks apart.

Body skin laxity treatments?

Body skin laxity following weight loss — typically affecting the abdomen, inner arms, and inner thighs — responds to a combination of radiofrequency microneedling and biostimulatory injectables. Morpheus8 (InMode) delivers radiofrequency energy into the dermis and subdermis, stimulating collagen and elastin remodelling in lax skin; 2-3 sessions spaced 4-6 weeks apart are standard. Hyperdiluted Radiesse can be used as a complementary injectable biostimulator across larger body surface areas. Ultraformer MPT (HIFU, Classys) targets the SMAS layer of the face and neck when laxity accompanies facial volume loss.

Cost of full package?

A full post-weight-loss protocol addressing both face and body across 6 months involves multiple sessions and several product categories, making it impossible to quote a single fixed price before a clinical assessment. As a general reference in Brasília: Sculptra from R$ 2,900 to R$ 3,900 per vial; Morpheus8 body from R$ 6,000 to R$ 12,000 per session, depending on the area; Radiesse from R$ 2,900 to R$ 3,900 per syringe and HarmonyCa from R$ 2,900 to R$ 3,900 per session. Prices well below these ranges usually signal a technical warning rather than a better offer: over-diluted product, a vial split between patients, or limited experience with the technique. Exact costs are itemised at the initial consultation.

Timeline of treatments?

The full post-weight-loss aesthetic recovery protocol at INTI typically spans 4-6 months from first session to comprehensive review. The first two months focus on initiating facial biostimulation with Sculptra and beginning body skin remodelling with Morpheus8. Months two through four introduce further biostimulator sessions and faster-acting volumisers for interim facial correction. Months four through six complete the primary course and incorporate additional energy device sessions for the body. A photographic review at month six determines whether maintenance sessions are needed and at what frequency.

Body biostimulators

Post-weight loss aesthetic recovery in Brasília (Ozempic, bariatric)

Rapid weight loss — through GLP-1 drugs or bariatric surgery — deflates the face and loosens body skin faster than the body can adapt. Structured, multi-modal protocols address both consequences simultaneously.

Book Consultation

What happens to the face and body after rapid weight loss

"Ozempic face" is the medically recognised term for facial lipoatrophy — the hollowing of the cheeks, temples, and jawline that follows rapid weight reduction, regardless of whether the loss was driven by a GLP-1 receptor agonist, bariatric surgery, or significant dietary change. The mechanism is the same in each case: subcutaneous fat, which provides structural support to facial skin, is metabolised faster than the overlying tissue can retract or generate new collagen scaffolding. The result is an appearance that reads as aged, gaunt, or disproportionate relative to the patient's actual age and body composition goals.

"Mounjaro face" and "Mounjaro body" describe the same changes when the weight loss comes from tirzepatide (Mounjaro, Eli Lilly) — now more common than semaglutide (Ozempic, Wegovy; Novo Nordisk) among patients who come for this assessment. Tirzepatide acts on two receptors (GIP and GLP-1) and, in a 2025 head-to-head trial, produced greater average reductions in body weight and waist circumference than semaglutide over 72 weeks (Aronne et al., N Engl J Med 2025) — so the facial hollowing and body skin laxity that follow can be more marked. The assessment and the protocols on this page are the same whichever drug drove the loss. Dr. Thiago Perfeito does not prescribe or monitor GLP-1 or tirzepatide treatment; that stays with the patient's own physician.

At the body level, the same speed mismatch produces a different consequence: excess, lax skin over the abdomen, inner arms, and inner thighs. Unlike the face, where the primary deficit is volume and collagen density, the body presents primarily with dermal laxity and loss of skin elasticity — a distinct clinical target requiring distinct tools.

Both problems are real, both are treatable, and treating them together within a single coordinated protocol produces more coherent results than addressing each in isolation. The key clinical principle is sequencing: structural facial rebuilding typically precedes body skin tightening, because the face is the first feature others perceive and biostimulator results require several months to mature before the full correction can be assessed.

Weight stability is a clinical prerequisite — ongoing significant loss undermines any injectable or energy-based intervention. This is assessed at the initial consultation before any protocol is proposed.

Ask a question on WhatsApp →

Treatment protocols: face and body

The clinical approach at INTI is deliberately multi-modal. No single product or device addresses the full spectrum of post-weight-loss aesthetic change. Protocols are built individually, but the following framework reflects how interventions are typically sequenced and combined.

Facial volume and collagen restoration:

Sculptra (poly-L-lactic acid, Galderma) — the preferred first-line agent for diffuse facial volume loss. Sculptra stimulates fibroblast activity, progressively rebuilding the collagen scaffold. Results develop over 8-12 weeks per session and accumulate across 2-3 sessions.
Radiesse (calcium hydroxyapatite, Merz) — provides immediate structural definition alongside biostimulation, well-suited to the lower face: jawline, chin, and pre-jowl area.
HarmonyCa (HA + CaHA hybrid, Allergan) — delivers rapid volumisation with a biostimulatory component, useful when the patient needs faster interim correction while Sculptra sessions are progressing.

Body skin laxity:

Morpheus8 (radiofrequency microneedling, InMode) — targets dermis and subdermis of the abdomen, inner arms, and inner thighs, stimulating collagen and elastin remodelling in lax post-weight-loss skin. Typically 2-3 sessions spaced 4-6 weeks apart.
Ultraformer MPT (HIFU, Classys) — SMAS-level tightening for face and neck, complementing injectable work where skin laxity accompanies volume loss.

Treatment timeline and cost context

Post-weight-loss aesthetic recovery is not a single appointment. Understanding the realistic timeline helps patients commit to the process and evaluate results at appropriate intervals.

Typical timeline: During months one and two: initial consultation, clinical photography, and weight-stability confirmation. First Sculptra session (face). First Morpheus8 session (body, if indicated). No immediate dramatic change is expected — biostimulators require time to work.

During months two through four: second Sculptra session, with assessment of collagen response. If rapid interim volume is needed, HarmonyCa or Radiesse may be introduced for focal areas. Patients typically begin to notice improved facial density by the end of this period.

During months four through six: third Sculptra session if indicated. Ultraformer MPT for neck and lower face if skin laxity remains after injectable work. Full photographic review against baseline.

From month six onwards: maintenance strategy is defined — typically one Sculptra session every 12-18 months for facial maintenance, and energy device touch-ups annually for body areas.

Regarding cost: Sculptra in Brasília ranges from R$ 2,900 to R$ 3,900 per vial; Morpheus8 body from R$ 6,000 to R$ 12,000 per session, depending on the area. Prices well below these ranges usually signal a technical warning rather than a better offer: over-diluted product, a vial split between patients, or limited experience with the technique. A detailed cost estimate is provided during the initial consultation, after the clinical assessment defines the specific interventions required.

Dr. Thiago Perfeito has no commercial relationship with any manufacturer mentioned on this page.

Last reviewed 30 September 2026 by Dr. Thiago Perfeito, CRM-DF 23199.

Dr. Thiago Perfeito

CRM-DF 23199 · Aesthetic and Regenerative Medicine

Physician with more than 10 years of practice in aesthetic and regenerative medicine. Master's degree in Aesthetic Medicine (2024). International training at Harvard Medical School and Mayo Clinic. Member of ASLMS, A4M, AMS, and NYAS. Practicing in Brasília, Lago Sul.

Learn about Dr. Thiago →

Frequently asked questions about Post-weight loss aesthetic

What is Ozempic face?

Ozempic face is a clinically recognised term for the facial lipoatrophy — hollowing of the cheeks, temples, and jawline — that follows rapid or significant weight loss, whether caused by semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), bariatric surgery, or dietary-driven weight reduction. The mechanism is loss of subcutaneous facial fat faster than the overlying skin can retract or the dermis can produce new collagen. The face takes on an aged, gaunt, or deflated appearance that is often inconsistent with the patient's overall health and age. It is not a side effect exclusive to GLP-1 drugs — the same process occurs with any rapid weight loss.
What is Mounjaro face (and Mounjaro body)?

Mounjaro face is the same facial lipoatrophy described as Ozempic face — hollowing of the cheeks, temples, and jawline — when the weight loss comes from tirzepatide (Mounjaro, Eli Lilly), a dual GIP and GLP-1 receptor agonist now more common than semaglutide (Ozempic, Wegovy) among patients who come for this assessment. Mounjaro body is the matching loss of skin firmness over the abdomen, inner arms, and inner thighs. In a 2025 head-to-head trial, tirzepatide produced greater average weight loss than semaglutide, so these changes can be more marked. Treatment follows the same assessment as any rapid weight loss: facial volume and collagen restoration with biostimulators, and body laxity treated with biostimulators and radiofrequency microneedling once weight is stable.
How to restore facial volume?

Facial volume restoration after significant weight loss requires rebuilding both the collagen scaffold and the structural volume that has been lost. Sculptra (poly-L-lactic acid, Galderma) is typically the first-line choice: it stimulates progressive collagen synthesis over 3-6 months and addresses the underlying structural deficit rather than simply filling space. For patients who need faster interim results, HarmonyCa (HA plus CaHA hybrid, Allergan) or Radiesse (calcium hydroxyapatite, Merz) provide immediate volumisation alongside biostimulatory effects. Most patients require 2-3 sessions of the primary biostimulator, spaced 4-8 weeks apart.
Body skin laxity treatments?

Body skin laxity following weight loss — typically affecting the abdomen, inner arms, and inner thighs — responds to a combination of radiofrequency microneedling and biostimulatory injectables. Morpheus8 (InMode) delivers radiofrequency energy into the dermis and subdermis, stimulating collagen and elastin remodelling in lax skin; 2-3 sessions spaced 4-6 weeks apart are standard. Hyperdiluted Radiesse can be used as a complementary injectable biostimulator across larger body surface areas. Ultraformer MPT (HIFU, Classys) targets the SMAS layer of the face and neck when laxity accompanies facial volume loss.
Cost of full package?

A full post-weight-loss protocol addressing both face and body across 6 months involves multiple sessions and several product categories, making it impossible to quote a single fixed price before a clinical assessment. As a general reference in Brasília: Sculptra from R$ 2,900 to R$ 3,900 per vial; Morpheus8 body from R$ 6,000 to R$ 12,000 per session, depending on the area; Radiesse from R$ 2,900 to R$ 3,900 per syringe and HarmonyCa from R$ 2,900 to R$ 3,900 per session. Prices well below these ranges usually signal a technical warning rather than a better offer: over-diluted product, a vial split between patients, or limited experience with the technique. Exact costs are itemised at the initial consultation.
Timeline of treatments?

The full post-weight-loss aesthetic recovery protocol at INTI typically spans 4-6 months from first session to comprehensive review. The first two months focus on initiating facial biostimulation with Sculptra and beginning body skin remodelling with Morpheus8. Months two through four introduce further biostimulator sessions and faster-acting volumisers for interim facial correction. Months four through six complete the primary course and incorporate additional energy device sessions for the body. A photographic review at month six determines whether maintenance sessions are needed and at what frequency.

Discuss your recovery protocol

An initial consultation at INTI clinic, Lago Sul, Brasília, begins with a clinical assessment of your degree of facial deflation and body skin laxity, followed by a clear, itemised treatment plan and realistic timeline. Dr. Thiago Perfeito (CRM-DF 23199) sees patients from the diplomatic community and international residents.

Book on WhatsApp Browse all procedures